日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A First-in-Class mAb (BI-1607) Targeting FcγRIIB: Preclinical Data and First-in-Human Studies in Patients with HER2-Positive Advanced Solid Tumors

首个靶向FcγRIIB的单克隆抗体(BI-1607):HER2阳性晚期实体瘤患者的临床前数据和首次人体研究

Cortés, Javier; Priego, Araceli; Garralda, Elena; Rojas, Katerin; Lord, Simon R; Goetze, Thorsten O; Kuemmel, Sherko; Crabb, Simon J; Parra-Guillen, Zinnia P; Borggren, Marie; Karlsson, Ingrid; Lindahl, Danijela; Mårtensson, Linda; Oldham, Robert; Ropenga, Anna; Teige, Ingrid; Wallin, Johan; Frendeus, Björn; McAllister, Andres

A "Function-First" Approach to Identify Regulatory T cell-Targeting Antibodies for Immunotherapy

采用“功能优先”方法鉴定用于免疫治疗的靶向调节性T细胞的抗体

Kirstie L S Cleary # ,Monika Semmrich # ,Linda Martensson ,Ulla-Carin Tornberg ,David Ermert ,Martin C Taylor ,Robert J Oldham ,Osman Dadas ,Josephine F Buckingham ,Jinny Kim ,H T Claude Chan ,Angelica Palm ,Ann-Helen Fischer ,Mimoza Boden ,Jenny Mattsson ,Petra Holmkvist ,Sean H Lim ,Stephen A Beers ,Bjorn Frendeus ,Ingrid Teige ,Mark S Cragg

FcγRIIB (CD32B) antibodies enhance immune responses through activating FcγRs

FcγRIIB (CD32B) 抗体通过激活 FcγR 增强免疫反应

Simpson, Alexander P; Oldham, Robert J; Cox, Kerry L; Taylor, Martin C; James, Sonya; White, Ann L; Bogdanov, Yury; Glennie, Martin J; Frendeus, Björn; Cragg, Mark S; Roghanian, Ali

FcγRIIB controls antibody-mediated target cell depletion by ITIM-independent mechanisms

FcγRIIB通过不依赖于ITIM的机制控制抗体介导的靶细胞耗竭。

Alexander P Simpson ,Ali Roghanian ,Robert J Oldham ,H T Claude Chan ,Christine A Penfold ,Hyung J Kim ,Tatyana Inzhelevskaya ,C Ian Mockridge ,Kerry L Cox ,Yury D Bogdanov ,Sonya James ,Alison L Tutt ,Daniel Rycroft ,Peter Morley ,Lekh N Dahal ,Ingrid Teige ,Björn Frendeus ,Stephen A Beers ,Mark S Cragg